Revelation Biosciences, Inc.
REVB
$1.01
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.74M | 1.72M | 1.61M | 1.02M | 1.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.66M | 3.09M | 2.57M | 1.94M | 2.46M |
| Operating Income | -3.66M | -3.09M | -2.57M | -1.94M | -2.46M |
| Income Before Tax | -3.32M | -3.01M | -2.51M | -1.91M | -2.44M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.32M | -3.01M | -2.51M | -1.91M | -2.44M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.32M | -3.01M | -2.51M | -1.91M | -2.44M |
| EBIT | -3.66M | -3.09M | -2.57M | -1.94M | -2.46M |
| EBITDA | -3.65M | -3.09M | -2.57M | -1.94M | -2.45M |
| EPS Basic | -0.87 | -2.71 | -1.65 | -7.07 | -28.04 |
| Normalized Basic EPS | -0.54 | -0.59 | -1.03 | -1.80 | -7.61 |
| EPS Diluted | -0.87 | -2.71 | -1.65 | -7.07 | -28.04 |
| Normalized Diluted EPS | -0.54 | -0.59 | -1.03 | -1.80 | -7.61 |
| Average Basic Shares Outstanding | 3.83M | 3.21M | 1.52M | 661.20K | 200.70K |
| Average Diluted Shares Outstanding | 3.83M | 3.21M | 1.52M | 661.20K | 200.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |